Medical devices, healthcare technology and the business of care
510(k) clearance · K254095

25G Huber Needle

Martech Medical Products · Decision date Sep 18, 2026

MEDTECHLEDGER EXPLANATIONK254095

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for K254095, the 25G Huber Needle submitted by Martech Medical Products of Harleysville, Pennsylvania, with a decision date of September 18, 2026. The device is a hypodermic non-coring right-angle needle with an LDPE protective tube, a female luer-lock connected through an extension, an in-line clamp, a gauge ID tag and winged hub, classified under 21 CFR 880.5570 as a Class II hypodermic single lumen needle, product code PTI, in the General Hospital panel.

The submission is a traditional 510(k), not third-party reviewed and not a combination product, so SESE reflects clearance rather than PMA approval. The stated predicate is the Huber Needle Infusion Set (K200463), cleared April 7, 2021, held by Jiangsu Caina Medical Co., Ltd; the summary states differences were assessed as raising no new questions of safety or effectiveness. The public record does not include the underlying test data or a detailed comparison of the changed features.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General Hospital
Decision date
Sep 18, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254095
Regulatory pathway
510(k) premarket notification
Product code
PTI
Decision code
SESE
Decision date
Sep 18, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Non-Coring (Huber) Needle.

Product code
PTI
FDA device class
2

FDA decision timeline

  1. K254095 received

    Application receipt date recorded by FDA.

  2. K254095 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Martech Medical Products

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Harleysville, PA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records